Logo
x

Search category

Subscribe Now

Hidradenitis Suppurativa

AbbVie & Eisai's Humira (adalimumab) Receives Approval for Hidradenitis Suppurativa in Japan

AbbVie & Eisai's Humira (adalimumab) Receives Approval for Hidradenitis Suppurativa in Japan

  • February 22, 2019
Image

Incisive News in 3 Shots.

Contact Us

Our Information

Follow Us

Copyright © 2023 PharmaShots - All Rights Reserved.